Methyl 5-(1H-indazol-3-yl)furan-2-carboxylate, 97%, 1g

Lithium chloride, min. 99%, pa, ACS, 50 g, plastic packaging.

Plan phase S100x/1.25 oil immersion infinity corrected objective

cis-3-(Benzyloxy)cyclobutanamine, 95.0%, 500mg

2-(Aminoethyl)-1-N-Boc-pyrrolidine, 97.0%, 250mg

5-Chloroimidazo[1,2-a]pyridine, 95.0%, 10g

3-Methoxy-2-(piperidin-4-yloxy)pyridinehydrochloride, 1g

4-(2-Fluorophenyl)thiazole, 95%, 1g

Benzyl N,N,N',N'-Tetraisopropylphosphorodiamidite>98.0%(GC)(T)5g

3,4-Dimethoxybenzamidoxime, 95.0%, 1g

6-Chloro-2-methylimidazo[1,2-b]pyridazine, 95.0%, 25g

2,6-Dimethyl-3-nitrophenol, 97%, 1g

2,3-Dihydrobenzo[b]furan-3-one, 95.0%, 1g